Curex
New York
About Curex
Curex offers the most accessible and convenient form of allergy immunotherapy in the U.S. Our at-home offering starts at just $59/month and results in better outcomes and 3x higher adherence than traditional allergy shots. With over 50,000 users across the U.S., Curex is trusted by hundreds of doctors and is in-network with over 80% of health plans.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Last round: Series Unknown (Jul 2024)
- Website: getcurex.com
- Phone: (857) 240-1080
Industries & Categories
Health Care, Telehealth, Wellness
Social Profiles
Canonical: https://fsome.com/organization/curex-184757 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.